Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.30B | $5.13B | $5.70B | $5.14B | $5.01B | $4.78B | $5.32B | $4.86B |
| Cost of revenue | $3.12B | $3.15B | $3.44B | $3.15B | $3.02B | $2.77B | $3.04B | $2.84B |
| Gross profit | $2.18B | $1.98B | $2.26B | $1.99B | $1.99B | $2.01B | $2.28B | $2.03B |
| Gross margin | 41.2% | 38.5% | 39.7% | 38.7% | 39.6% | 42.1% | 42.8% | 41.7% |
| Research and development | $323.00M | $345.00M | $323.00M | $292.00M | $302.00M | $344.00M | $344.00M | $316.00M |
| Selling, general and administrative | $1.12B | $1.12B | $1.11B | $1.05B | $1.03B | $1.04B | $1.13B | $1.03B |
| Operating expenses | $1.44B | $1.46B | $1.15B | $1.34B | $1.33B | $1.38B | $1.07B | $1.35B |
| Operating income | $739.00M | $515.00M | $1.11B | $653.00M | $654.00M | $629.00M | $1.21B | $676.00M |
| Operating margin | 14.0% | 10.0% | 19.6% | 12.7% | 13.1% | 13.2% | 22.7% | 13.9% |
| EBITDA | $899.00M | $668.00M | $1.26B | $801.00M | $802.00M | $765.00M | $1.35B | $819.00M |
| Interest expense | −$114.00M | −$96.00M | −$105.00M | −$111.00M | −$113.00M | −$110.00M | −$121.00M | −$130.00M |
| Income before taxes | $693.00M | $505.00M | $821.00M | $643.00M | $613.00M | $692.00M | $834.00M | $658.00M |
| Income taxes | $119.00M | $94.00M | $219.00M | $179.00M | $113.00M | $104.00M | $96.00M | $168.00M |
| Net income | $574.00M | $411.00M | $602.00M | $464.00M | $500.00M | $588.00M | $738.00M | $490.00M |
| Net margin | 10.8% | 8.0% | 10.6% | 9.0% | 10.0% | 12.3% | 13.9% | 10.1% |
| EPS, basic | $1.24 | $0.85 | $1.30 | $0.98 | $1.06 | $1.23 | $1.59 | $1.03 |
| EPS, diluted | $1.24 | $0.85 | $1.29 | $0.98 | $1.06 | $1.23 | $1.57 | $1.02 |
| Diluted shares | 454.00M | 457.00M | 458.00M | 457.00M | 458.00M | 459.00M | 459.00M | 459.00M |
Figures describe GE HealthCare Technologies shares, not any token. As of Jul 29, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.